EGFR and neoplasm: This effort was achieved through the use of three tumor cell lines (A431, AsPC-1, and 9L) with varying EGFR expression levels (Fig. 1), alongside benign adipose tissue to ensure retention of similar tumor-to-adipose (T/A) contrast, which is required for successful margin assessment during BCS.